Vaccine and Immunotherapy Technologies
9-11 April 2008, Canberra
Vaccine and Immunotherapy Technologies brings together eminent experts from around the world for a vibrant and cutting-edge conference program.
The conference provides a balanced and diverse insight into the rapidly evolving scientific area of vaccines and immunotherapy. It showcases the most recent high-tech basic science concepts in vaccine and immunotherapy research, and highlights the challenges of deployment and delivery of vaccines in the real world.
Speakers from Australia, Asia, Europe and the US discuss the many severe research and applied challenges that remain in the fields of vaccines and immunotherapy, but also present current success stories such as the introduction of the first vaccine against cervical cancer.
Vaccine and Immunotherapy Technologies is jointly managed by the Australian Academy of Science and the Australian Academy of Technological Sciences and Engineering.
> > Media releases
Program Organising Committee:
- Professor Ian Frazer, FAA, FTSE, (Chair), Centre for Immunology and Cancer Research, University of Queensland.
- Professor Peter Gray, FTSE, Australian Institute for Bioengineering and Nanotechnology, University of Queensland.
- Professor Ian Gust, FTSE, Department of Microbiology and Immunology, University of Melbourne.
- Professor Graham Mitchell, FAA, FTSE, Foursight Associates Pty Ltd.
- Professor Ian Ramshaw, John Curtin School of Medical Research, Australian National University.
Program
WEDNESDAY 9 APRIL
| 9.00am | Welcome Professor Kurt Lambeck, PresAA, FRS Australian Academy of Science |
9.05am | Opening Address Senator The Honourable Jan McLucas Parliamentary Secretary to the Minister for Health and Ageing |
| 9.15am | Wednesday Plenary Address Professor Ian Frazer, FAA, FTSE Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland Controlling cancer through immunisation - a glass half full? |
SESSION 1: Vaccine and immunotherapy super challenges
Chair: Professor Ian Ramshaw
John Curtin School of Medical Research, Australian National University
| 10.00am | Dr Wayne Koff International AIDS Vaccines Initiative, USA Accelerating AIDS vaccine development: Challenges and opportunities |
| 11.00am | Professor Warwick Britton Central Clinical School, University of Sydney; Mycobacterial Research Group, The Centenary Institute of Cancer Medicine and Cell Biology New solutions to the challenge of vaccines for tuberculosis |
| 11.30am | Dr Louis Schofield The Walter and Eliza Hall Institute of Medical Research, Melbourne Prospects for the development of an anti-toxic vaccine against malaria |
| 12.00pm | Professor Andy Morgan School of Medical Sciences, University of Bristol, UK Prophylactic and therapeutic vaccines against Epstein-Barr virus and its associated cancers |
SESSION 2: Vaccine and immunotherapy super challenges (continued)
Chair: Professor Ian Gust, FTSE
Department of Microbiology and Immunology, University of Melbourne
| 1.30pm | Dr Peter Daniels CSIRO Australian Animal Health Laboratory Emerging antigenic mismatch between H5N1 avian influenza field strains and available vaccines: The animal health response |
| 2.00pm | Professor Hualan Chen National Avian Reference Laboratory, Harbin, China Development and application of vaccines for H5N1 avian influenza |
| 2.30pm | Professor Lawrence Stanberry College of Physicians and Surgeons of Columbia University, USA Herpes simplex virus vaccine development: Insights and conundrums |
SESSION 3: Vaccine and immunotherapy super challenges (continued)
Chair: Professor Kenneth K Wu
National Health Research Institutes, Taiwan
| 3.30pm | Professor Eric Gowans Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne Dendritic cell immunotherapy to treat patients with persistent hepatitis C virus infection |
| 4.00pm | Dr Deborah Fuller Center for Immunology and Microbial Disease Albany Medical College, Albany, USA Immunotherapeutic DNA vaccines for HIV: Increased immune function and viral control in the nonhuman primate model for AIDS |
THURSDAY 10 APRIL
SESSION 4: Optimising vaccine delivery
Chair: Professor Peter Gray, FTSE
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
| 8.45am | Thursday Plenary Address Associate Professor Eugene Maraskovsky CSL Limited, Australia ISCOMATRIX® adjuvant for prophylactic and therapeutic vaccines |
| 9.30am | Associate Professor David Jackson National Health and Medical Research Council of Australia, University of Melbourne Simple synthetic lipid structures target vaccine cargos to dendritic cells |
| 10.00am | Professor Rajiv Khanna Australian Centre for Vaccine Development, Queensland Institute of Medical Research Multiepitope vaccines for the prevention of Herpesvirus associated diseases |
SESSION 5: Rational design and regulatory issues of immunotherapeutic vaccines
Chair: Professor Peter Colman, FAA, FTSE
Structural Biology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne
| 11.00am | Dr Anne De Groot Epivax Inc; Brown University Center for Genomics and Proteommics, USA Computer-driven vaccine design: From concept to reality |
| 11.30pm | Professor Zihe Rao Nankai University, Tianjin, China Structural proteomics of the SARS coronavirus: Structure, function and interaction of the replicase proteins |
| 12.00pm | Professor Stephen Kent Department of Microbiology and Immunology, University of Melbourne Immunotherapy of HIV |
SESSION 6: Vaccine development and deployment: non-technical constraints
Chair: Professor Kenneth K Wu
National Health Research Institutes, Taiwan
| 2.00pm | Dr Luc Hessel Sanofi Pasteur MSD, Lyon, France Transfer of technology as a solution to vaccine access? |
| 2.30pm | Professor Anton Middelberg, FTSE Centre for Biomolecular Engineering, University of Queensland The downstream self-assembly bioprocessing of virus-like vaccines |
SESSION 7: Vaccine procurement, distribution and delivery in the developing world
Chair: Ms Beth Slatyer
Australian Agency for International Development (AusAID), Canberra
| 3.30pm | Dr John Clemens International Vaccine Institute, South Korea New approaches to evaluating vaccine herd protection: Implications for future trials of vaccines against enteric infections |
| 4.00pm | Dr Julian Lob-Levyt Global Alliance for Vaccines and Immunization, Switzerland Delivering the promise: New markets, new money and new models of development aid |
CONFERENCE DINNER
| 7.00pm | Dinner speaker Dr Norman Swan Science Unit, ABC Radio National |
FRIDAY 11 APRIL
SESSION 8: Immune regulation and strategies to identify protective responses
Chair: Professor Graham Mitchell, FAA, FTSE
Foursight Associates, Melbourne
| 8.45am | Friday Plenary Address Sir Gustav Nossal, FAA, FTSE The University of Melbourne Global immunisation: Recent trends in research and programme delivery |
| 9.30am | Professor Takashi Nishimura Institute for Genetic Medicine, Hokkaido University, Japan Tumor vaccine cell therapy to overcome tumor escape mechanisms |
| 10.00am | Dr Nathalie Garçon GlaxoSmithKline Biologicals, Belgium Using novel adjuvants to improve vaccine performance |
| 11.00am | Associate Professor David Sinclair Department of Pathology, Harvard Medical School, Boston, USA Accelerating vaccine discovery for multiple pathogens using ORFeome screening technologies |
| 11.30am | Dr Gabrielle Belz Division of Immunology, The Walter and Eliza Hall Institute of Medical Research, Melbourne Intrinsic and extrinsic regulation of protective immune responses in pathogen infections |
| 12.00pm | Professor Jonathan Sprent, FAA Immunology and Inflammation Research Programme, Garvin Institute of Medical Research, Sydney Stimulating subsets of T cells with cytokine/antibody complexes |
